SDOT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
SDOT is not a good buy right now. With no Intellectia buy signals, no recent news catalysts, and extremely weak latest-quarter fundamentals (Q3 2025 revenue collapse and deep losses), the risk/reward is unfavorable for an impatient buyer who doesn’t want to wait for a cleaner setup. This is a sell/avoid at current levels around $3.17.
Price/Trend: Trading around the pivot (~3.176) with converging moving averages, suggesting a non-directional/indecisive trend. Momentum: MACD histogram is positive (0.0476) but “positively contracting,” implying bullish momentum is fading rather than accelerating. RSI(6) ~52 is neutral (no edge). Levels: Pivot 3.176. Near-term resistance: R1 3.478 then R2 3.664. Support: S1 2.874 then S2 2.688. Current price near pivot means limited immediate upside edge unless it breaks and holds above ~3.48. Pattern-based outlook: Similar-pattern stats imply slightly negative skew (60% chance of ~-0.97% next day; ~+0.49% next week; ~-0.55% next month) — not compelling for immediate buying.
Intellectia Proprietary Trading Signals
No news in the recent week (no clear event-driven catalyst). Pre-market is modestly higher (+1.25%), but this alone is not a durable catalyst without volume/confirmation above resistance (~3.48).
Latest quarter shows severe deterioration (Q3 2025 revenue down ~99.86% YoY; net income far worse YoY; EPS deeply negative; gross margin extremely negative), which can drive continued selling pressure and limit institutional appetite.
No supportive flow signals: hedge fund and insider trends are neutral; no Intellectia buy signals today.
No recent news: absence of catalysts reduces the probability of a sharp, sustained upside move.
Congress/politician activity: no recent congress trading data available (no “influential buyer” signal).
Latest quarter: 2025/Q3. Revenue fell to ~$289K (-99.86% YoY). Net income dropped to about -$15.19M (much worse YoY). EPS was about -17.42 (much worse YoY). Gross margin is deeply negative. Overall, the quarter indicates a major operational/financial breakdown versus last year, showing negative growth trends and weak quality of earnings.
No analyst rating or price target change data was provided, so there’s no observable Wall Street upgrade/downgrade trend to support a near-term buy thesis. With fundamentals deteriorating sharply and no visible Street-sponsored catalyst, the pro/con tilt from available data leans negative.
